The Only Dedicated Community for Continuous Manufacturing Commercialization
From Implementation to Digitalization: Reaping Commercial Continuous Processing Benefits to Ensure Manufacturing Capacity, Accelerate Speed-to-Market & Optimize Flexible cGMP Manufacturing
The 5th Commercializing Continuous Processing in Pharma 2021 reunited the growing CCP community to discuss how to accelerate adoption of continuous processing in a GMP environment.
We have reached the inflection point that continuous manufacturing is a must-have capability for drug developers and CMOs – as it offers tremendous opportunities to fast track treatments to patients through flexible manufacturing for rapid response and emerging therapeutics.
More important than ever, the industry and patients need a flexible and agile option to scale-up, guaranteeing capacity for speed-to-market. As the only meeting dedicated to commercial continuous manufacturing, this is the definitive summit to meet, share and be inspired by both small molecules and biologics pioneers.
Who Attended in 2021?